Loading... Please wait...
About Us
Contact Us
Privacy Policy
Sign in
or
Create an account
My Account
View Cart
Checkout
Search
Home
Report Subject
Generics/Biosimilars
Browse by
Biosimilar Index
Dossier
FirstView
FirstView NPS+
FirstWord Pharma
Therapy Trends
Therapy Trends Updates
Latest Reports
Therapy Area Reports
Report Subject
Emerging Markets
Generics/Biosimilars
Market Access
Medical Affairs
Pharma Marketing
Pharma Sales
Technology/Digital Health
Orphan Drugs
Sort by:
Featured Items
Newest Items
Bestselling
Alphabetical: A to Z
Alphabetical: Z to A
Next »
Pages:
1
2
3
4
Learn More
Biosimilars: Go-to-Market Case Studies
As the biosimilar sector matures, what are the key issues that are shaping commercial strategies? As physician and payer confidence in the use of biosimilars grows, US and European companies are having to rethink their...
Compare
Learn More
The Role of Patient Journey Mapping in Patient Engagement
Are you employing the latest technology and techniques to power your patient journey mapping? "Pharma companies first need to understand that their task is not to produce new product; their task is to provide a really...
Compare
Learn More
Biomarkers and Companion diagnostics: Payer Insights
What do you need to do to get payer support for companion diagnostics and biomarkers? The investment decisions made by the biggest players in core disease areas drive market trends—so it's crucial to understand...
Compare
Learn More
Trends in Investment by Big Pharma
What direction are big pharma investments taking? The investment decisions made by the biggest players in core disease areas drive market trends—so it's crucial to understand where the big money is going and why...
Compare
Learn More
Biosimilars: The Importance of Real-World Evidence (2019)
Are you generating the right RWE to influence the right stakeholders? As the biosimilar sector continues to evolve and experience of their use deepens, what role should real-world evidence (RWE) now take in stakeholder...
Compare
Learn More
Pharma-Tech Partnerships: Key Success Factors
What does an ideal Pharma-Tech partnership look like? Learn from Merck, Sanofi, Boehringer Ingelheim and UCB With tech companies making their presence felt in the health market and a demand for greater efficiency...
Compare
Learn More
Commercialisation of Biosimilars: Current Best Practice and Future Trends
The key to commercial success for biosimilars? Find out what the experts say The biosimilars market is in a state of flux as key players in the US and Europe actively seek to improve perceptions, shape the market, and...
Compare
Learn More
Orphan Drugs: The Importance of Real-World Evidence
Current expert thinking on how real-world evidence can refine orphan drug research, demonstrate stakeholder value and prove clinical effectiveness. Alarmed at the number of often highly-priced orphan drugs coming to...
Compare
Learn More
The State of Pharma Digital Transformation
How digitally mature is pharma? What progress has pharma made to embrace the digital age? Are digital strategies robust enough? Are appropriate capabilities and organisational structures in place? How culturally ready...
Compare
Learn More
Time to Market: Accelerating Market Access
Building the most effective strategy for fast track market access Getting to market faster clearly has benefits, but there are also potential downsides for drug companies too. You need to know the options and consider...
Compare
Learn More
Biosimilars: US Payer Insights (2019)
What do payers see as critical to unlocking the stalled US biosimilar sector? How do payers view the trends in the sluggish US biosimilar market and what initiatives do they want from pharma? Originator companies are...
Compare
Learn More
A new Era in Pharma Marketing: Delivering Content-Driven Experiences
Are you locked in a traditional product marketing mind set? Time to move on... How can you provide better support and awareness to HCPs and patients for your brands? Content marketing may be the answer. Advocates argue...
Compare
Learn More
Biologics Life Cycle Management: Tactics and Strategies in the Biosimilars Era
The biologics competitive landscape is at a critical stage of development. How will you respond? Biosimilars are on the offensive across Europe and beyond. With the recent launches of multiple new biosimilars to compete...
Compare
Learn More
Pharma-patient engagement: Patient centricity comes of age
Are you truly patient-centric or just ticking boxes? Find out how your strategy compares Until relatively recently, patient centricity was commonly seen as just a useful talking point and the catalyst for some...
Compare
Learn More
Orphan Drugs: US Payer Perspectives
So what will persuade US payers to better support orphan drugs? US payer concern at the number of new orphan drugs coming to market, often with eye watering prices attached, can obscure a more positive message: payers...
Compare
Learn More
Orphan Drugs: European Payer Perspectives
European payers reveal how pharma can build trust and gain their support for orphan drug products European payers are concerned about orphan drugs citing unjustified high prices and a lack of evidence of utility and...
Compare
Next »
Pages:
1
2
3
4
About Us
Contact Us
Privacy Policy
customer.service@firstwordpharma.com
All Contents Copyright © 2021 Doctor's Guide Publishing Limited All Rights Reserved